Health Care
  • GSK clinches deal to buy Human Genome for $3 billion

    GSK clinches deal to buy Human Genome for $3 billion

    By Ben Hirschler and Toni Clarke, Reuters

    LONDON/BOSTON (Reuters) - GlaxoSmithKline Plc is to acquire its long-time partner Human Genome Sciences Inc for a sweetened offer of about $3 billion, ending on friendly terms a three-month hostile...

  • Exclusive: GSK set for Human Genome takeover - sources

    Exclusive: GSK set for Human Genome takeover - sources

    By Soyoung Kim and Ben Hirschler, Reuters

    NEW YORK/LONDON (Reuters) - GlaxoSmithKline is expected to announce a deal to buy Human Genome Sciences for about $2.8 billion as soon as Monday, ending a three-month hostile pursuit of the U.S...

  • Scientists see AIDS vaccine within reach after decades

    Scientists see AIDS vaccine within reach after decades

    By Julie Steenhuysen, Reuters

    CHICAGO (Reuters) - At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two...

  • Insight: As lawsuits climb, J&J may have new hip trauma

    Insight: As lawsuits climb, J&J may have new hip trauma

    By Debra Sherman, Reuters

    CHICAGO (Reuters) - Johnson & Johnson faces a potentially more damaging and costly sequel to the $3 billion recall of its ASR all-metal artificial hips two years ago, one of the most expensive...

  • Scathing report faults Penn State leaders in child sex abuse

    Scathing report faults Penn State leaders in child sex abuse

    By Dave Warner and Mark Shade, Reuters

    PHILADELPHIA (Reuters) - Penn State leaders including the late football coach Joe Paterno covered up Jerry Sandusky's sexual abuse of children for years, showing a callous disregard for the victims...